• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center


    DF/HCC Members Presented with 2014 AACR Awards

    April 14, 2014

    Congratulations to Levi Garraway and Rakesh Jain, who were among the 2014 American Association for Cancer Research (AACR) awardees:

    Levi Garraway (DFCI) was awarded the AACR-Minorities in Cancer Research Jane Cooke Wright Lectureship for his research in the field of cancer genomics and functional approaches to characterize solid tumors, especially melanoma and prostate cancer

    Bromodomain Inhibition: Helping Cancer Cells “Forget”

    April 2014 | eNews

    The TPETT program, with its mission to facilitate the development of new anticancer agents from the preclinical to the clinical stages, relies on basic research to provide new compounds for study

    DF/HCC TPETT Program: Testing novel therapeutics in phase I and II trials

    April 2014 | eNews

    As researchers delve ever deeper into the underpinnings of cancer biology, more therapeutic targets emerge; targets that, when attacked, will in theory shut down the growth of cancer cells—ideally while sparing healthy cells

    High-Throughput Polymorphism Detection

    April 2014 | eNews

    The DF/HCC High-Throughput Polymorphism Detection Core provides services to Cancer Center members conducting molecular analyses of germline and somatic DNA collected as part of a wide range of investigations into the molecular epidemiology of cancer, including Genome Wide Association Studies (GWAS)

    Drew Memmott Joins DF/HCC as the New Associate Director for Administration

    April 2014 | eNews

    Drew Memmott has recently joined DF/HCC as the new Associate Director for Administration

    DNA Resource Core

    April 2014 | eNews

    The DF/HCC DNA Resource Core provides researchers with quality and inexpensive sequencing and plasmid services paired with comprehensive quality control and customer support

    Cancer Killing Nanoparticles Home in on Their Target

    January 2014 | eNews

    While cytotoxic chemotherapy remains the cornerstone of most cancer treatment, therapeutic approaches are becoming ever more targeted, with the goal of killing cancer cells while avoiding damage to healthy cells

Displaying results 1 to 7 out of 206
<< First < Previous 1-7 8-14 15-21 22-28 29-35 36-42 43-49 Next > Last >>